We aimed to predict the abnormal LDL level by using TG, TC, HDL, and non-HDL in this study.
Background
Triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL) are commonly used in clinical practice as a part of routine lipid evaluation [1] . Testing of cholesterol is vital in patients with diabetes, stroke, and heart diseases [3] . Normally, tests for serum TG, TC, HDL, and LDL are ordered together in the clinical laboratory. Since LDL is a component of the TC and the change of LDL is closely correlated to TC in most cases, we hypothesized that LDL testing might not be necessary, especially if both TC and non-HDL are within normal limits. Thus, we proposed that serum abnormal LDL level could be predicted by using TC and non-HDL as reflex tests. Reflex testing was defined as automatically adding or removing a test by the biochemical analyzer for saving clinical laboratory costs. For example, serum total bilirubin (TBIL) and conjugated bilirubin (CBIL) are highly correlated and approximately 87% of CBIL test results are lower than TBIL test results [4] . Most labs in Europe and the United States use automated technology to perform lipid profiles with automatic calculation of LDL by Friedewald method; however, all LDL levels are measured using a direct clearance method on auto biochemical analyzers in China. The results of LDL by Friedewald equation are often discordant with the direct clearance method results, and the cost of the direct clearance method is higher than for the indirect method. LDL may not accurately reflect the true level of LDL [3] and the elevated LDL should be measured by direct method. Hence, we searched for a novel method for estimating LDL levels. In this study, we analyzed the correlation between TG, TC, non-HDL, and LDL.
Material and Methods
Study cohort and data extraction TG, TC, HDL, and LDL data were obtained from the Laboratory Information System (LIS). There were 34 270 subjects (21 651 males and 12 619 females) ( Table 1 ) who came for routine health check-ups from October 2013 to September 2017 in Shuyang People's Hospital. Since these individuals denied any complaints and did not have any medical history, we considered them as apparently healthy individuals. Data on age, sex, fasting serum TG (GPO-PAP no correction), TC (cholesterol oxidase method), HDL (direct clearance method), and LDL (direct clearance method) were extracted from the LIS. TG, TC, HDL, and LDL were measured using a TBA2000FR biochemical analyzer (Toshiba ® Co., Ltd., Japan). Regular quality control procedures are conducted daily in the Laboratory Medicine Unit of Shuyang People's Hospital. The external quality assessment scheme of Jiangsu Center for Clinical Laboratories is performed twice a year to validate the quality of these results.
The Ethics Committee of Shuyang People's Hospital approved this study on Feb 15, 2017.
Statistical analysis and calculation
Non-HDL was calculated as TC minus HDL [1] and their relationship was analyzed using Spearman's correlation. For abnormal LDL level, receiver operating characteristics (ROC) curve analysis was used to evaluate the predictive accuracy of TG, TC, HDL, and non-HDL. LDL was considered to be abnormal if >130 mg/dL (3.36 mmol/L) [5, 6] . All statistical analyses were performed using EXCEL ® 2007 (Microsoft Corporation, Beijing, China) and MedCalc ® 15.2.2 (MedCalc Software, Ostend, Belgium). A p value less than 0.05 was considered statistically significant.
Results

The characteristics of the subjects
The data on 34 270 pairs of cholesterol and triglyceride tests between October 1, 2013, and September 30, 2017 were extracted from the Health Examination Center of Shuyang People's Hospital, including 21 651 males and 12 619 females (Table 1) . All data is represented bymedian and interquartile range.
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The optimal threshold of TC and non-HDL in predicting abnormal LDL level Figure 2 shows the ROC curves of TG, TC, HDL, and non-HDL for predicting abnormal LDL level (<130 mg/dL). Areas under the curve (AUC) were 0.675, 0.950, 0.541, and 0.957 for TG, TC, HDL, and non-HDL, respectively. As listed in Table 2 , non-HDL was markedly better than TC for predicting abnormal LDL level in terms of diagnostic performance and leakage in different TG levels. At these threshold values of TC and non-HDL, <2.6% and 1.8% of tests with elevated LDL would have been missed, but the missing elevated LDL was not very high (<147.3 mg/dL=3.81 mmol/L). As listed in Table 3 , when the non-HDL is <135.3 mg/Dl (3.50 mmol/L) and/or TC is <182.5 mg/dL (4.72 mmol/L), the LDL will be <130 mg/dL for the all the population. If the non-HDL is under 139.2 mg/dLl (3.60 mmol/L) and/ or TC is under 182.5 mg/dL (4.72 mmol/L), the LDL will be low 130 mg/dL for the population (the TG is less than 400 mg/dL).
Discussion
In this study, we analyzed serum TG, TC, non-HDL, LDL and their correlations in a large Chinese cohort of apparently healthy Table 2 . The optimal threshold and accuracy of total cholesterol and non-high density lipoprotein cholesterol, and its performance in predicting abnormal low-density lipoprotein cholesterol.
* Compare with TC and nonHDL groups; TC -total cholesterol; nonHDL -non-high density lipoprotein cholesterol; LDL -low-density lipoprotein cholesterol.
LDL levels (<130 mg/dL) were easily be predicted using TC and non-HDL. Given the diagnostic performance and the proportion of elevated LDL, non-HDL is notably better than TC for predicting abnormal LDL levels. Two optimal thresholds of TC and non-HDL for predicting abnormal LDLC level were 182.5 mg/dL (4.72 mmol/L) and 139.2 mg/dL (3.60 mmol/L) (given TG is <400 mg/dL). If TC is <182.5 mg/dL and/or non-HDL [7] , which is considered inaccurate (TG level is more than 220 mg/dL) [8] , in this study we took into account the cost savings but also screened out the abnormal LDL level, and it was not affected by triglyceride levels.
Conclusions
There are some limitations to this study. First, this was a single-center study on individuals who came from routine health check-ups. Second, some individuals (<0.5%) with abnormal LDL levels can still be missed.
The results of present study indicate that almost all abnormal LDL levels can be predicted by using TC and/or non-HDL. To the best of our knowledge, this study is the first to predict LDL level by using ROC curve analysis. The approach of this study may be suited for other subjects. However, because of differences in the detection system and subjects, optimal threshold should be based on local data for using TC and/or non-HDL to predict abnormal LDL level.
